NHMRC CTC

@TrialsCentre

A diverse group of researchers with an outstanding reputation for improving global health outcomes through high-quality clinical trials and research.

Sydney, Australia
Vrijeme pridruživanja: ožujak 2012.

Tweetovi

Blokirali ste korisnika/cu @TrialsCentre

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TrialsCentre

  1. prije 1 sat

    Administering Viagra to women in labour reduces foetal distress by 51%, says PHASE II study led by and supported by CTC's ABC reported pilot results in Nov19

    Poništi
  2. 5. velj
    Poništi
  3. 4. velj

    Exciting times for -HiCaP trial which opens for recruitment end Feb/start March! Determining effectiveness of adding darolutamide to therapy for men with very high risk localised prostrate cancer

    Poništi
  4. 2. velj

    "Don’t underestimate giving encouragement and inspiring confidence in others, particularly as a mentor. This was a huge influence on my career." Our Director, Professor John Simes shares some key lessons learned during his 30 year career.

    Poništi
  5. 31. sij

    Funding good news continues with the ANZCTR receiving $100k from NCRIS (NSW Govt). ANZCTR is a CTC-run registry of all clinical trials in Aus & NZ (85-90% of all trials) informing researchers what has been and what is underway

    Poništi
  6. 30. sij

    CTC is coordinating a trial (led by ALTG) that uses precision medicine to improve treatments for lung cancer patients. Recruiting patients from July 2020. Part of our Molecular Screening & Therapeutics program together with

    Poništi
  7. 27. sij

    CTC Director, Prof John Simes, received an AO award in the Aus Day Honours List for his service to cancer research and clinical trials. John is everything the CTC stands for and we could not be prouder!

    Poništi
  8. 23. sij

    Syd SOLD OUT but tickets still available in MELB and BRIS

    Poništi
  9. proslijedio/la je Tweet

    International experts in Bayesian Adaptive Randomisation, Dr Lorenzo Trippa & Dr Steffen Ventz of , are coming to Syd & Melb to present two-day workshops on innovative clinical trial designs & their analysis. Read more & register:

    Prikaži ovu nit
    Poništi
  10. 19. sij

    Our is co-hosting ACTA's webinar on Research Prioritisation on 17 Feb.

    Poništi
  11. 7. sij

    Our phd gun has rec'd a NHMRC scholarship for her study of next gen systematic reviews & meta-analyses. Well done Saskia!

    Poništi
  12. 18. pro 2019.

    Our AUTO-CHECK trial - studying side effects from immunotherapy for cancer patients - has recruited +250 patients! Incl. brain, endometrial, lung, renal cell cancers, mesothelioma

    Poništi
  13. 16. pro 2019.

    Very happy for our who has just been promoted to full Professor for her leadership in health econ & health services research, mentoring and teaching of PhD & research students, and roles in various committees 🥳

    Poništi
  14. 12. pro 2019.

    Xmas brings out our creative and competitive sides :-)

    Poništi
  15. 9. pro 2019.

    Great news: our methods experts behind ideas grant TOPCHILD - looking at the early prevention of childhood obesity - just received NHMRC funding!

    Poništi
  16. 4. pro 2019.
    Poništi
  17. 28. stu 2019.

    was key behind The Cardiovascular Precision Medicine Symposium held earlier this week at . Opened by Hon. . Industry stakeholders discussed 10 yr plan towards precision in diagnosing & treating cardiovascular disease

    Poništi
  18. 20. stu 2019.

    The trial, which we run in support of , featured in a CH9 news story...

    Poništi
  19. 18. stu 2019.

    Patients with incurable breast cancer want to know how long they have left to live so they can plan appropriately but average life expectancies given are only accurate 20-30% of the time says

    Poništi
  20. 17. stu 2019.

    Deputy Director, Professor Anthony Keech, believes the vital ingredient at the heart of effective clinical trials is 'one very good question'.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·